Therapeutic Antibodies for Research/Reference Use

Evidentic specializes in providing clinical-grade therapeutic molecules, such as monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), fusion proteins, and bi-specifics, repackaged as research consumables. This innovative approach allows researchers to access these difficult-to-source molecules in small quantities, which are essential for various research applications. The company offers drug aliquots that contain original therapeutic molecules manufactured by the original drug license holders, ensuring high quality and reliability. These aliquots are available in different batches and concentrations, making them suitable for a wide range of research needs without the requirement for licensing.

In addition to supplying drug aliquots, Evidentic also provides analytical data packages to support the drug development process. Researchers can request comprehensive or tailored analysis packages to gain insights into the therapeutic molecules they are working with. This service not only accelerates the research timeline but also enhances the ability to characterize proteins and assess the efficacy of novel molecules. Evidentic's commitment to fast, accurate, and secure delivery of these products empowers researchers globally, facilitating advancements in the life sciences and biotherapeutics fields.

Germany

What we do: we supply therapeutic molecules of clinical-grade quality for R&D and early drug development.

Our solution: we repackage pharmaceuticals. So, we offer aliquots of clinical-grade mAbs, bs-mAbs, fusion proteins, ADCs, and other biologics as laboratory consumables. As an additional service, we provide analytical data to accompany each aliquot.

Your advantage: you can order therapeutic molecules in clinical-grade quality as research consumables. Fast . Easy. Cost efficient.

Evidentic

Company Details